Special Fraud Alert: Speaker Programs

by Karin Chernoff Kaplan, Director
and Monica Nuñez, Manager

Open PDF file >

In November 2020, the Department of Health and Human Services Office of Inspector General (OIG) issued a Special Fraud Alert related to speaker programs sponsored by pharmaceutical and medical device companies. Specifically, the Alert centered on the OIG’s significant and longstanding concerns regarding fraud and abuse risks associated with remuneration for such programs. Speaker programs—events […]

One Size Does Not Fit All: Your Ambulatory Services Must Be Tailored to the Value Equation of Each Consumer Segment

by Mark J. Dubow, Director
and Ross Shuster, Senior Associate

If your ambulatory network is the only provider in town, and it is providing high-quality services at reasonable rates that meet the community’s needs, those characteristics will likely position your organization for success. But what happens when your organization is surrounded by competitors (including some of the new entrants) fighting for market share? How do […]

Micro-Hospitals: Short-Term Fad or Promising Market Growth Strategy?

by Meredith Inniger, Manager

Many conversations we have with hospital and health system executives about market growth strategies eventually turns to the topic of micro-hospitals — and for good reason. These facilities typically include a small-scale emergency department (ED), low-acuity surgery, and are often comprised of eight to 10 inpatient beds as well as additional observation beds (notably, these […]

What Does CVS-Aetna Have in Store for Hospitals?

by Scott Stuecher, Manager, Veralon

Open PDF file >

Twelve years after launching the retail health insurgency with the purchase of the start-up MinuteClinic, CVS Health is upping the ante. In the biggest deal of 2017, CVS Health acquired Aetna in December. At this point, all predictions about how this merger will impact hospitals and health systems are conjecture. However, hospital leaders would be […]

Ten Questions Lawyers and Clients Ask About FMV Valuations

by Jessica E. Stack, Manager; Denise Palencik, Senior Associate;
Karin Chernoff Kaplan, Director
AHLA Business Law & Governance
May 2016

Open PDF file >

Nearly every health care business transaction must be based on some measure of fair market value (FMV). Although the attorney’s role in the preparation of a valuation to support a transaction is limited, most attorneys recognize the need to critically evaluate the opinions they and their clients obtain from valuation experts. Attorneys assist in setting expectations, and helping clients understand why their “back of the envelope” valuation may be unrealistic. This article answers questions that lawyers and their clients commonly ask during the business valuation process.

DGA Partners Merges with Health Strategies & Solutions to form Veralon

DGA Partners and Health Strategies & Solutions, healthcare management consulting firms, have merged to form a single consultancy, to be known as Veralon Partners. “This is a merger between equals with many complementary services,” says Daniel M. Grauman, who is Managing Director and CEO of the new firm. “It will allow us to better serve […]